Clinical and molecular characterization of Costello syndrome in unrelated Mexican patients

Clin Dysmorphol. 2022 Apr 1;31(2):55-58. doi: 10.1097/MCD.0000000000000405.

Abstract

This study intends to describe for the first time a cohort of Mexican patients with Costello syndrome. The five exons of the HRAS gene were amplified in DNA samples from 13 patients with a clinical suspicion of Costello syndrome. PCR products were sequenced using the Ready Reaction Big Dye Terminator v.3.0 Kit and an ABI PRISM 310 sequencer. Only five patients (38%) showed causal variant in codon 12 of the HRAS gene (four with the p.Gly12Ser and one with the p.Gly12Ala variant). Three patients showed silent polymorphic variants (p.His27His and p.Leu159Leu). Clinical features in patients carrying the causal variant were variable. The alternative diagnosis of cardio-facio-cutaneous syndrome was considered in patients who did not have a causative variant in HRAS.

MeSH terms

  • Costello Syndrome* / diagnosis
  • Costello Syndrome* / genetics
  • Ectodermal Dysplasia*
  • Facies
  • Failure to Thrive
  • Humans
  • Mexico
  • Phenotype
  • Proto-Oncogene Proteins p21(ras)* / genetics

Substances

  • HRAS protein, human
  • Proto-Oncogene Proteins p21(ras)